Valuation (17%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 782.13 | N/A |
PEG Ratio (TTM) | 51.78 | N/A |
P/S Ratio (TTM) | N/A | N/A |
P/B Ratio (TTM) | 3.66 | N/A |
P/FCF Ratio (TTM) | -125.05 | N/A |
Price to 5YR AVG Earnings Ratio | N/A | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (15%) |
Company | Industry |
---|---|---|
ROA (TTM) | 0.34% | N/A |
ROE (TTM) | 0.41% | N/A |
Net Profit Margin (TTM) | N/A | N/A |
ROIC 5YR AVG | N/A | N/A |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -246.40% | N/A | N/A |
Revenue | N/A | N/A | N/A |
Net Income | -123.26% | N/A | N/A |
Cash Flow | -20.92% | N/A | N/A |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.02 | N/A |
Quick Ratio (TTM) | 0.02 | N/A |
D/E Ratio (TTM) | 0.15 | N/A |
Interest Coverage (TTM) | -2.08 | N/A |
Piotroski F-Score | 3 | N/A |
Altman Z-Score | 4.67 | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | N/A | N/A |